spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Clinical Trial Supply West Coast Conference 2019

PCI Pharma Services

PCIs Rich Nelson to Discuss Best Practices in the Global Movement of Scheduled Drug Product

 Philadelphia, USA – April 24, 2019. This year’s Clinical Trial Supply West Coast Conference will see leading biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) showcasing its specialist clinical trials expertise in relation to scheduled drugs.

May 14-15, Burlingame, CA
(Hilton San Francisco Airport Bayfront)

Focusing on ‘Scheduled Drug – Processes and Complications in Global Logistics’, PCI’s Rich Nelson, Senior Manager, Global Logistics for Clinical Services, will present on Tuesday, May 14 at 9am PDT. Rich will share PCI’s significant experience, providing an overview of the differences and potential difficulties involved with the global movement of scheduled drugs. He will also discuss the impact of those processes on timelines and logistics plans for clinical trials.

In his role with PCI, Rich works with clients to provide seamless global distribution for their investigational drug products, ensuring cost-effective and time-efficient delivery throughout the clinical trials process.

“The process of handling scheduled drugs is highly complex, due to the inherent risks involved with the product, and the need for absolute compliance in its development, manufacturing and distribution. PCI has a long-standing track record of supporting clients across the world in this challenging area, and I am delighted to have the opportunity to share some of our insight and experience at the CTS West Coast event,” said Rich.

PCI recently announced expansion of its industry leading global controlled substance infrastructure, coinciding with new legislation from the US government in addressing concerns about the nations’ opioid crisis. PCI offers expertise in packaging and logistics for controlled substances, approved for Schedule I – V DEA designations. PCI’s domestic operations are located in Philadelphia, PA, Rockford, IL, and San Diego, CA, complemented by operations in the UK, Ireland and Australia.

PCI is a trusted partner for the global healthcare industry and has been providing development solutions that increase client’s products' speed to market and opportunities for commercial success. PCI has proven experience that comes with more than 50 successful product launches a year and over five decades in the healthcare business. Many clients view PCI as an extension of their business and a collaborative partner, with the shared goal of improving patients' lives.

For further information about PCI’s expertise in scheduled drug processes, please visit here.

About PCI
The global healthcare industry trusts PCI for the development solutions that increase their products' speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over five decades in the healthcare business. Leading technology and continued investment enables us to address global needs throughout the product life cycle — from preclinical development, clinical investigational studies, commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients' lives. For more information, please visit www.pciservices.com or follow us on Twitter at @PCI_Social.

Contact
Tom Gosschalk / Carrie Lowe at BECG

T: +44 (0)20 3697 7647 / +44 (0)1962 893 913
phone +44 (0)1495 713 633
email sales@pciservices.com
web www.pciservices.com
email Wye Valley Business Park, Hay-on-Wye, HR3 5PG
 
Print this page
Send to a friend
   
spacer
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>


White Papers

Running Smarter Trials With Data-Driven Monitoring

PAREXEL

Clinical monitoring remains one of the most important and most costly activities in the clinical research paradigm.  Monitoring provides the operational transparency required by investigators, sponsors, and regulators to make informed decisions about site performance, patient safety, and overall study progress. Yet unlike many clinical trial activities, which have been steadily transformed by technology, the monitoring function itself has changed little.
More info >>

Industry Events

BioPharm America™ 2019—12th Annual International Partnering Conference

11-12 September 2019, Boston Convention and Exhibition Center (BCEC), Boston, MA 02210 USA

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world’s leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. BioPharm America annually attracts 800+ delegates from over 500 companies who participated in 2,300+ scheduled one-to-one meetings. BioPharm America is now part of Biotech Week Boston, and together they draw a total of over 4,500 life science leaders, scientists and innovators.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement